NASDAQ:BCTX

Briacell Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy BCTX

*Your capital is at risk

$3.31

+0.0400 (+1.22%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

BCTX Prediction Chart

BCTX Predictions History

Latest community submissions for BCTX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Warren Pro	Feb 3, 2023	$6.95 -93.22%	$7.07	X	98.29%	1
petespaintwork.283253	Feb 3, 2023	Bullish	$7.07	X	—	1
JS Pro	Apr 25, 2022	$7.58 -93.22%	$7.09	X	93.09%	0
Bill Lose @BillLose.246931	Apr 25, 2022	Bullish	$7.09	X	—	1
JS Pro	Jul 19, 2021	$4.70 -93.05%	$4.51	V	95.79%	1
LdyFraknDrill	Jul 19, 2021	Bearish	$4.51	V	—	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BCTX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT BRIACELL THERAPEUTICS CORP.

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immun...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by